Related Experiment Video
Updated: Jul 20, 2026

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow
Published on: March 17, 2023
Stem cells--a clinical update
1Diabetes Transplant Unit, Prince of Wales Hospital and University of New South Wales. b.tuch@unsw.edu.au
Background:
Stem cells of adult origin have been used clinically for 40 years in the treatment of haematological neoplasms such as leukaemia. These cells were originally obtained from bone marrow, but are now also being derived from umbilical cord blood.
Objective:
With the increasing public awareness of stem cell use, general practitioners need to be aware for which disorders these cells can, and are, being used.
Discussion:
Recent clinical trials with stem cells have been for ischaemic heart disease and to assist nonunion of bone. Other adult stem cells used in clinical trials include olfactory cells for spinal cord lesions, and human fetal pancreatic cells for type 1 diabetes. Adult stem cells, however, have limited potential to differentiate into different cell types. Human embryonic stem cells can be converted into cells of all lineages. They first became available for research in 1998 but are yet to be used in clinical trials.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Embryonic Stem Cells
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Embryonic Stem Cells
Stem Cell Culture
Mesenchymal Stem Cells
Induced Pluripotent Stem Cells
Somatic cells are...

